Pill For Metastatic Pancreatic Cancer Helped Patients Live Twice As Long

Pill For Metastatic Pancreatic Cancer Helped Patients Live Twice As Long Stat reported that patients who took the daily pill, called daraxonrasib, lived a median of 13.2 months compared with 6.7 months for patients who received chemotherapy. One of the trial's participants, former U.S. Sen. Ben Sasse of Nebraska, said, "This experience has seemingly extended both quantity and quality of [my] life.” https://kffhealthnews.org/morning-breakout/pill-for-metastatic-pancreatic-cancer-helped-patients-live-twice-as-long/